CLARK, NJ – The first commercial trial of mPRO Care, launched by Mobile Health Tech at Clarkstown Medical Associates, PC in New York, touts a two-way mobile diabetes solution that provides automated reminders and accepts readings using standard cell phones on all major U.S. service providers.

mPRO Care was developed to help improve patient medication and treatment compliance for improved healthcare outcomes and reduced cost of care for patients with chronic conditions such as Diabetes, Coronary Artery Disease and Hypertension, Asthma and Obesity.

There are currently over 23 million diabetics in the U.S., about 8 percent of the total population, with approximately 2 million new diabetics diagnosed each year.

Clarkstown Medical Associates, an internal medicine practice, is offering mPRO Care for its diabetes patients, in this trial, to evaluate its effectiveness in helping manage this hard to control disease.

The solution sends custom tailored medication reminders, motivational and behavioral trigger messages, and condition reading requests to patient cell phones in the form of text messages (SMS). Diabetes patients text back their blood sugar readings which are captured and plotted on a patient diary card graph in a secure portal for online access by either patient or physician.

"In today's mobile lifestyle, it has become increasingly difficult for many patients with chronic conditions to be medication and treatment compliant," said Howard Feldfogel, MD, CMA partner and chief of medicine at Nyack Hospital. "The mPRO Care system offers potential to help patients improve their compliance and management of diabetes and other chronic conditions."

Bob Gold, president of Mobile Health Tech, said, "Because the solution is software as a service (SAAS), there is no hardware or software to install. In a matter of hours, a medical practice can begin to use mPRO Care to enhance patient care, reduce costs and improve outcomes."